Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Barostimulation in Cardiac Hemodynamics and Clinical Outcomes Through Use of the Barostim™ CVRx Device

NCT07335510 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT07335510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07335510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Barostimulation in Cardiac Hemodynamics and Clinical Outcomes Through Use of the Barostim™ CVRx Device
Lead sponsor
Columbia University
Phase
Not applicable
Overall status
Recruiting
Start date
March 30, 2026
Completion date
March 31, 2028
Enrollment
58 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hfref - heart failure with reduced ejection fraction